Non-invasive Prenatal Testing Market Growth Opportunities: Insights from 2025–2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Non-invasive Prenatal Testing Market Expected To Expand Between 2025 And 2029?
The non-invasive prenatal testing market has seen significant expansion in its size recently. This market is anticipated to grow from $5.48 billion in 2024 to $6.27 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be ascribed to improved accuracy, reduced risk, increased maternal age, growing awareness, and established clinical guidelines.
The non-invasive prenatal testing market is anticipated to observe significant expansion in the next few years. It is projected to attain a valuation of $10.86 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.7%. The impetus for this growth during the forecast period stems from factors such as expanding test offerings, broader accessibility, an increase in maternal age, enhanced fetal anomaly detection, and the integration of telemedicine and digital health. Key trends identified for the forecast period involve broader test panels, greater adoption of NIPT, ongoing technological advancements, and the development of non-invasive fetal aneuploidy diagnosis (NIFAD).
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp
Which Major Market Drivers Are Shaping The Future Of The Non-invasive Prenatal Testing Market?
A significant factor propelling the non-invasive prenatal testing market is the high rate of Down syndrome cases, coupled with an increase in the average maternal age, which raises concerns about the fetus’s growth and safety. Down syndrome is a chromosomal disorder resulting from an error in cell division that causes an extra chromosome 21, potentially impacting the fetus’s cognitive abilities and physical development. NIPT screening tests are beneficial as they are non-invasive, causing no harm to the mother or baby and carrying no risk of miscarriage, while effectively detecting more than 99% of Down syndrome cases. According to the National Down Syndrome Society and Centers for Disease Control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome, and 80% of children with this condition are born to older mothers. This heightened risk of older women having babies with Down syndrome is a key driving force behind the growth of the non-invasive prenatal testing market.
What Are The Major Segment Categories Driving The Non-invasive Prenatal Testing Market Growth?
The non-invasive prenatal testingmarket covered in this report is segmented –
1) By Type: Consumables; Instruments
2) By Application: Trisomy; Microdeletion; Genetics; Rh factor
3) By End User: Hospital; Diagnostic Labs
Subsegments:
1) By Consumables: Assay Kits; Reagents; Disposables
2) By Instruments: Next-Generation Sequencers (NGS); Polymerase Chain Reaction (PCR) Systems; Ultrasound Devices; Others (Microarrays And Mass Spectrometers)
Which Ongoing Trends Are Expected To Shape The Non-invasive Prenatal Testing Market Outlook?
Next-generation sequencing has enhanced throughput, scalability, and speed, enabling researchers to conduct a wide array of applications and study biological systems at a more profound level. This platform facilitates the simultaneous sequencing of thousands to millions of DNA molecules. Manufacturers have introduced this technology to minimize required time and money, optimizing output for generating results concerning genome and DNA testing. Major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have implemented this technology in non-invasive prenatal testing. The CFDA (China Food and Drug Administration) has approved the medical instrument product registration for Annoroad’s NGS instrument, the NextSeq 550AR.
Which Industry Leaders Are Driving Innovation Across The Non-invasive Prenatal Testing Market?
Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
What Are The Key Regional Factors Influencing The Non-invasive Prenatal Testing Market Growth?
North America was the largest region in the non-invasive prenatal testing market in 2024. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Non-invasive Prenatal Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp
Browse Through More Reports Similar to the Global Non-invasive Prenatal Testing Market 2025, By The Business Research Company
Hormonal Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Molecular Diagnostics Devices And Equipment Global Market Report 2025
Prenatal Testing And Newborn Screening Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model